[Value of Eusaprim suspension in pediatrics].
D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005759:Gastroenteritis / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007239:Infections / Q000188:drug therapy*; D008297:Male; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Intérêt de l'Eusaprim suspension en pédiatrie.